Host Jeremy C. Park talks with Kelley Marshburn, Development Director for the Alzheimer’s Association Tennessee Chapter, who highlights the nonprofit organization’s efforts and mission to “lead the way to end Alzheimer’s and all other dementia – by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.”
During the interview, Kelley discusses how the Alzheimer’s Association is the largest nonprofit funder of Alzheimer’s disease research, and the latest drug that received full FDA approval on July 6, 2023, Lecanemab, is the first one ever to target the cause of the disease, not just the symptoms. Kelley talks about their advocacy and support programs and the importance of the Walk to End Alzheimer’s, which is the organization’s largest fundraising campaign with over 600 walks across the nation. She highlights the event in Memphis, which will be held Saturday, October 21, 2023, and the event in Nashville, which will be held Saturday, November 4, 2023, and how the community can get involved in supporting their efforts and the events.
Visit www.alz.org to learn more.